Effects of androgen administration in men with the AIDS wasting syndrome. A randomized, double-blind, placebo-controlled trial

Annals of Internal Medicine

Volumn 129, Issue 1, 1998, Pages 18-26

  Grinspoon, Steven ^a   Corcoran, Colleen ^a   Askari, Hasan ^b   Schoenfeld, David ^a   Wolf, Lisa ^c   Burrows, Belton ^d   Walsh, Mark ^d   Hayden, Douglas ^a   Parlman, Kristin ^a   Anderson, Ellen ^a   Basgoz, Nesli ^a   Klibanski, Anne ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOSLIN DIABETES CENTER   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; PLACEBO; TESTOSTERONE ENANTATE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EXERCISE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; MALE; MUSCLE MASS; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; WASTING SYNDROME;

EID: 7144257865     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-129-1-199807010-00005     Document Type: Article

References (39)

1. Kotler DP, Wang J, Pierson RN. Body composition studies in patients with the acquired immunodeficiency syndrome. Am J Clin Nutr. 1985;42:1255-65.
2. Kotler DP, Tierney AR, Wang J, Pierson RN Jr. Magnitude of body-cell-mass depletion and the timing of death from wasting in AIDS. Am J Clin Nutr. 1989;50:444-7.
3. Suttmann U, Ockenga J, Selberg O, Hoogestraat L, Deicher H, Muller MJ. Incidence and prognostic value of malnutrition and wasting in human immunodeficiency virus-infected outpatients. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;8:239-46.
4. Dobs AS, Dempsey MA, Ladenson PW, Polk BF. Endocrine disorders in men infected with human immunodeficiency virus. Am J Med. 1988;84(3 Pt 2): 611-6.
5. Grinspoon S, Corcoran C, Lee K, Burrows B, Hubbard J, Katznelson L, et al. Loss of lean body mass and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting. J Clin Endocrinol Metab. 1996;81:4051-8.
6. Bhasin S, Storer TW, Berman N, Yarasheski KE, Clevenger B, Phillips J, et al. Testosterone replacement increases fat-free mass and muscle size in hypogonadal men. J Clin Endocrinol Metab. 1997;82:407-13.
7. Brodsky IG, Balagopal P, Nair KS. Effects of testosterone replacement on muscle mass and muscle protein synthesis in hypogonadal men - a clinical research center study. J Clin Endocrinol Metab. 1996;81:3469-75.
8. Katznelson L, Finkelstein JS, Schoenfeld DA, Rosenthal DI, Anderson EJ, Klibanski A. Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism. J Clin Endocrinol Metab. 1996;81:4358-65.
9. Tenover JS. Effects of testosterone supplementation in the aging male. J Clin Endocrinol Metab. 1992;75:1092-8.
10. Urban RJ, Bodenburg YH, Gilkison C, Foxworth J, Coggan AR, Wolfe RR, et al. Testosterone administration to elderly men increases muscle strength and protein synthesis. Am J Physiol. 1995;269(5 Pt 1):E820-6.
11. Revision of the CDC surveillance definition for acquired immunodeficiency syndrome. Council of State and Territorial Epidemiologists: AIDS Program, Center for Infectious Diseases. MMWR Morb Mortal WkIy Rep. 1987;36 Suppl 1: 3S-15S.
12. Mazess RB, Barden HS, Bisek JP, Hanson J. Dual-energy x-ray absorptiometry for total-body and regional bone-mineral and soft-tissue composition. Am J Clin Nutr. 1990;51:1106-12.
13. Heymsfield SB, Arteaga C, McManus C, Smith J, Moffitt S. Measurement of muscle mass in humans: validity of the 24-hour urinary creatinine method. Am J Clin Nutr. 1983:478-93.
14. Mendez J, Buskirk ER. Creatinine-height index. Am J Clin Nutr. 1971;24:385-6.
15. Kushner RF, Schoeller DA. Estimation of total body water by bioelectrical impedance analysis. Am J Clin Nutr. 1986;44:417-24.
16. Forbes GB, Lewis AM. Total sodium, potassium and chloride in adult man. J Clin Invest. 1956;35:596-600.
17. 1983 Metropolitan height and weight tables. Statistical Bulletin of the Metropolitan Life Foundation. 1983;64:3-9.
18. Shils ME, Olson JA, Shike M, eds. Modern Nutrition in Health and Disease. Philadelphia: Lea & Febiger; 1994:829-34.
19. Spiekerman AM. Proteins used in nutritional assessment. Clin Lab Med. 1993;13:353-69.
20. Harris JA, Benedict FG. A Biometrie Study of Basal Metabolism in Man. Washington, DC: Carnegie Institute of Washington; 1919.
21. Oster MH, Enders SR, Samuels SJ, Cone LA, Hooton TM, Browder, HP, et al. Megestrol acetate in patients with AIDS and cachexia. Ann Intern Med. 1994;121:400-8.
22. Kohl HW, Blair SN, Paffenbarger RS Jr, Macera CA, Kronenfeld JJ. A mail survey of physical activity habits as related to measured physical fitness. Am J Epidemiol. 1988;127:1228-39.
23. Csuka M, McCarty DJ. Simple method for measurement of lower extremity muscle strength. Am J Med. 1984;78:77-81.
24. Guyatt GH, Thompson PJ, Berman LB, Sullivan MJ, Townsend M, Jones NL, et al. How should we measure function in patients with chronic heart and lung disease? J Chron Dis. 1985;38:517-24.
25. Podsiadlo D, Richardson S. The timed "Up & Go": a test of basic functional mobility for frail elderly persons. J Am Geriatric Soc. 1991;39:142-8.
26. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Normal reference laboratory values. N Engl J Med. 1992;327: 718-24.
27. Engelson ES, Rabkin JG, Rabkin R, Kotler DP. Effects of testosterone on body composition [Letter]. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;11:510-1.
28. Morley JE, Melmed S. Gonadal dysfunction in systemic disorders. Metabolism. 1979;28:1051-73.
29. Woolf PD, Hamill RW, McDonald JV, Lee LA, Kelly M. Transient hypogonadotropic hypogonadism caused by critical illness. J Clin Endocrinol Metab. 1985;60:444-50.
30. Veldhuis JD, Iranmanesh A, Evans WS, Lizarralde G, Thorner MO, Vance ML. Amplitude suppression of the pulsatile mode of immunoradiometric luteinizing hormone release in fasting-induced hypoandrogenemia in normal men. J Clin Endocrinol Metab. 1993;76:587-93.
31. Alexieva-Figusch J, Blankenstein MA, de Jong FH, Lamberts WJ. Endocrine effects of the combination of megestrol acetate and tamoxifen in the treatment of metastatic breast cancer. Eur J Cancer Clin Oncol. 1984;20:135-40.
32. Wachtel T, Piette J, Mor V, Stein M, Fleishman J, Carpenter C. Quality of life in persons with human immunodeficiency virus infection: measurement by the Medical Outcomes Study instrument. Ann Intern Med. 1992;116:129-37.
33. Rabkin JG, Rabkin R. Testosterone replacement therapy for HIV-infected men. AIDS Reader. 1995;July/August: 136-44.
34. Von Roenn JH, Armstrong D, Kotler DP, Cohn DL, Klimas NG, Tchekmeydian NS, et al. Megestrol acetate in patients with AIDS-related cachexia. Ann Intern Med. 1994;121:393-9.
35. Schambelan M, Mulligan K, Grunfeld C, Daar ES, LaMarca A, Kotler DP, et al. Recombinant human growth hormone in patients with HIV-associated wasting. A randomized, placebo-controlled trial. Serostim Study Group. Ann Intern Med. 1996;125:873-82.
36. Snyder PJ, Lawrence DA. Treatment of male hypogonadism with testosterone enanthate. J Clin Endocrinol Metab. 1980;51:1335-9.
37. Wortley PM, Fleming PL. AIDS in women in the United States. Recent trends. JAMA. 1997;278:911-6.
38. Grinspoon S, Corcoran C, Miller K, Biller BM, Askari H, Wang E, et al. Body composition and endocrine function in women with acquired immunodeficiency syndrome wasting. J Clin Endocrinol Metab. 1997;82:1332-7.
39. Miller K, Corcoran C, Armstrong C, Caramelli K, Anderson E, Cotton D, et al. Transdermal testosterone administration in women with AIDS wasting: a pilot study. J Clin Endocrinol Metab. 1998; [In press].